ArthroCare diversifies by entering ENT (ear, nose and throat) market
This article was originally published in Clinica
ArthroCare is to expand into the ear, nose and throat (ENT) market with its patented coblation technology and the formation of a new division, ENTec, to commercialise the technique. The expansion is part of ArthroCare's diversification strategy for its technology into markets other than arthroscopy.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.